Turtle Cameron
SEC-identified person · CIK 1758363 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Spyre Therapeutics, Inc. SYRE | Director · Chief Executive Officer | filed 2023–2026 |
| Galecto, Inc. GLTO | Director | filed 2026–2026 |
| Oruka Therapeutics, Inc. ORKA | Director | filed 2024–2025 |
| Eidos Therapeutics, Inc. EIDX | Chief Business Officer | filed 2018–2021 |
| Bridgebio Pharma, Inc. BBIO | See Remarks | filed 2019–2020 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.